Skip to content
Study details
Enrolling now

Serial MRI Scans During Radiation Therapy

Dana-Farber Cancer Institute
NCT IDNCT04188535ClinicalTrials.gov data as of Apr 2026
Target enrollment

149

Study length

about 11 years

Ages

18+

Locations

2 sites in MA

What this study is about

This trial is testing whether using serial magnetic resonance imaging (MRI) to assess treatment response during and after radiation therapy can be used for participants with advanced esophageal cancer, glioblastoma, prostate cancer, vulvar cancer or pediatric glioma. It involves three MRI scans before, during, and after standard of care cancer radiation therapy.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Undergo MRI IMAGING

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Ability to measure disease control (for imaging registry expansion cohort), Feasibility of acquiring serial MRI scans on an MRI simulator during treatment with radiation therapy

Procedures

imaging

Body systems

Oncology